Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Frontiers in Oncology|May 6, 2026
Case Report: Immunotherapy-induced Felty syndrome in a patient with metastatic melanomaLaura S Park, Caoimhe Byrne, Hayley Burridge, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 24, 2004
Nitric oxide donation lowers blood pressure in adrenocorticotrophic hormone-induced hypertensive ratsMiles C Andrews, Christopher G Schyvens, Yi Zhang, et al.Oncoimmunology|January 23, 2015
The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populationsLaura J Vella, Miles C Andrews, Anupama Pasam, et al.American Journal of Hypertension|April 28, 2004
Adrenocorticotropic hormone, blood pressure, and serum erythropoietin concentrations in the ratYi Zhang, Miles C Andrews, Christopher G Schyvens, et al.Journal of Hypertension|May 23, 2002
The nitric oxide system in glucocorticoid-induced hypertensionJudith A Whitworth, Christopher G Schyvens, Yi Zhang, et al.Melanoma Research|January 28, 2014
A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programmeDavid K Lau, Miles C Andrews, Natalie Turner, et al.Australian Journal of General Practice|June 9, 2023
Immune-related adverse events secondary to immunotherapy in oncology: A guide for general practiceHui-Ling Yeoh, Karen Freilich, Mark Voskoboynik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2015
Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic MelanomaMiles C Andrews, Natalie Turner, Janis Boyd, et al.Molecular Cancer|June 30, 2017
PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activationCandani S A Tutuka, Miles C Andrews, John M Mariadason, et al.Molecular Cancer|November 18, 2016
Systems analysis identifies miR-29b regulation of invasiveness in melanomaMiles C Andrews, Joseph Cursons, Daniel G Hurley, et al.Pageof 6